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Abstract 
Purpose: Capnocytophaga canimorsus (Cani) and Capnocytophaga cynodegmi (Cyno) are found in the oral cavities 
of dogs and cats. They can be transmitted to humans via licks or bites and cause wound infections as well as severe 
systemic infections. Cani is considered to be more pathogenic than Cyno, but the pathophysiological mechanisms are 
not elucidated. Cani has been suggested to be resistant to serum bactericidal effects. Thus, we hypothesized that the 
more invasive Cani would exhibit a higher degree of serum-resistance than the less pathogenic Cyno.
Methods: Whole blood and serum bactericidal assays were performed against Cani- (n = 8) and Cyno-strains 
(n = 15) isolated from blood and wound-specimens, respectively. Analysis of complement-function was performed 
by heat-inactivation, EGTA-treatment and by using C1q-depleted serum. Serum and whole blood were collected from 
healthy individuals and from patients (n = 3) with a history of sepsis caused by Cani.
Results: Both Cani and Cyno were equally susceptible to human whole blood and serum. Cani was preferentially 
killed by the classical pathway of the complement-system whereas Cyno was killed by a partly different mechanism. 
Serum from 2/3 Cani-infected patients were deficient in MBL-activity but still exhibited the same killing effect as con-
trol sera.
Conclusion: Both Cani and Cyno were readily killed by human whole blood and serum in a complement-dependent 
way. Thus, it is not likely that serum bactericidal capacity is the key determinant for the clinical outcome in Cani or 
Cyno-infections.
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Background
The gram negative bacteria Capnocytophaga canimorsus 
(Cani) and Capnocytophaga cynodegmi (Cyno) consti-
tute a significant part of the oral flora of dogs and cats 
(Suzuki et al. 2010). Cani was first described in 1976 and 
originally named dysgonic fermenter 2 (DF-2) (Bobo and 
Newton 1976). In the same report a ‘DF-2 like’ bacteria, 
mainly associated with wound infections, was described. 
Later, DF2 was named Capnocytophaga canimorsus 
(‘canimorsus’ is latin for ‘dogbite’) and “DF-2 like” Capno-
cytophaga cynodegmi (‘cynodegmi’ is greek for ‘dogbite’) 
(Brenner et  al. 1989). Cani can cause severe infections, 
including sepsis, meningitis or endocarditis, after con-
tact with dogs or cats (Oehler et  al. 2009). The clinical 
picture is characterized by a rapid onset a few days after 
animal contact, often with a fulminant course (Oehler 
et  al. 2009) and sometimes with neurological sequelae 
(Gasch et  al. 2009). In contrast to Cani, Cyno is not as 
well described, but the general notion is that Cyno mainly 
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is found in wound infections and rarely cause invasive 
infections. Most Cani-strains are susceptible to empirical 
treatment with ampicillin together with clavulanic acid 
(Oehler et al. 2009; Butler 2015).
The diagnostic microbiology is notoriously difficult, 
mainly due to the fastidious nature and slow growth 
on standard agar media. Cani and Cyno are facultative 
anaerobic bacteria that grow best on blood and hema-
tin agar plates. In addition, the presence of 5–10 % CO2 
and 48 h of incubation is needed for efficient growth and 
for typical colony morphology. After 18–24 h of incuba-
tion on blood agar plates, colonies are small (<0.5  mm) 
and may be irregular in shape. After 48  h, the colonies 
become visible (1–3 mm) and can vary in size and shape, 
within the same isolate or species. In gram staining, the 
bacteria are thin and fusiform with pointed ends (Bren-
ner et al. 1989). Traditional methods require several days 
for diagnosis, but the introduction of novel methods, 
such as MALDI-TOF, in clinical bacteriology has signifi-
cantly shortened the time to diagnosis (Zangenah et  al. 
2012).
Patient with congenital or acquired asplenia or with a 
dysfunctional spleen, alcoholics and elderly people con-
stitute risk groups for severe Cani infections (Shahani 
and Khardori 2014; Ugai et al. 2014). However, there are 
only a few reports on Cani pathogenesis. For example, 
Cani has been shown to block the release of proinflam-
matory cytokines from monocytes (Shin et  al. 2007). 
Recently, it was shown that Cani has a deglycosylation 
system that degrades exposed sugars on human IgG and 
on epithelial cell surfaces (Renzi et al. 2011). Finally, Cani 
has been described to be ‘serum resistant’ to 10 % New 
Zealand rabbit serum (Butler et al. 1985) and to normal 
human serum (Shin et al. 2009), but Cani has also been 
shown to be sensitive to normal human serum (Hicklin 
et al. 1987). Thus, the interactions between Cani and the 
immune system are not completely understood but it is 
possible that one or several of the described immune eva-
sive features could contribute to the high virulence previ-
ously reported for infections with Cani.
In contrast to Cani, there is very limited knowledge on 
the role of human immunity in Cyno-infections. Cyno 
is more often reported in the case of wound infections 
and there is only two reports on invasive Cyno-infection 
(Khawari et al. 2005; Sarma and Mohanty 2001), whereas 
there are many case reports on invasive Cani-infections. 
Thus, if serum survival is a key virulence trait of Cani, it 
should be more resistant in serum than the presumably 
less virulent Cyno. To answer this question, we used a 
collection of clinical isolates of Cani and Cyno collected 
at the Karolinska University Laboratory between 2007 
and 2010 and used traditional whole blood and serum 
bactericidal assays. The role of the complement system 
was dissected by the use of heat inactivation, calcium 
chelation and C1q-depleted sera. In addition, sera from 
patients deficient in mannose binding lectin (MBL-) 
activity were used. Finally, sera from patients with a pre-
vious history of sepsis with Cani were used in an attempt 
to elucidate pathophysiological mechanisms.
Methods
Reagents
Blood and hematin agar plates and phosphate buffered 
saline were manufactured by the Substrate Unit at Karo-
linska University Hospital, Stockholm, Sweden, which is 
accredited by SWEDAC (Swedish Board for Accredita-
tion and Conformity Assessment).
Collection of human serum
Venipuncture tubes without anticoagulants were used to 
obtain serum. Serum was aliquoted and stored in −80° 
until use in experiments. Sera from n  =  7 healthy vol-
unteers were pooled and constituted the “pooled serum” 
used in this study (ethical approval 2000/360/00, Stock-
holm Board of Ethics for Medical Research). The pooled 
serum was analyzed by Clinical Immunology, Karolinska 
University Laboratory, Stockholm, Sweden for comple-
ment activity and levels of immunoglobulins. Normal 
values were found for all analyzed parameters, includ-
ing the alternative pathway (118 %), the classical pathway 
(97 %) and the lectin pathway (39 %), C3 (1.17 g/L), C4 
(0.21  g/L) as well as IgG (12.7  g/L) and IgM (1.09  g/L). 
Additional sera from n  =  12 additional healthy volun-
teers were collected and tested individually. Heat inac-
tivated serum (HIS) was obtained by heating at 56  °C 
for 30  min, which inactivated the complement system. 
Pooled serum was treated with 10  mM EGTA-MgCl to 
inhibit the Ca2-dependent classical pathway and the lec-
tin pathway (Abdullah et  al. 2005). C1q-depleted serum 
was purchased from Millipore/Calbiochem, USA. The 
sera from mannose binding lectin (MBL) deficient 
patients were collected as part of another study (Berg-
man et  al. 2012) under the ethical approval 2009/1678-
31/4 (Stockholm Board of Ethics for Medical Research). 
Sera from patients with a previous history of Cani-sepsis 
were collected as part of the FUNGEN-study (ethical 
approval 2011/116-31/4, unpublished). Written informed 
consent was obtained from all patients.
Bacterial strains
A total of 23 clinical strains were included in the study 
and they have been extensively characterized in a previous 
study (Zangenah et al. 2012). Eight strains of C. canimorsus 
were isolated from blood cultures and fifteen strains of C. 
cynodegmi were isolated from wound specimens. In addi-
tion, the reference strains ATCC 35978 (C. canimorsus, 
Page 3 of 9Zangenah and Bergman  SpringerPlus  (2015) 4:517 
blood isolate), ATCC 49045 (C. cynodegmi, wound isolate) 
were used as controls. To validate the system of serum 
killing we obtained two Salmonella strains from the LT2-
background; SL3769 (rfaG-mutant, serum sensitive) and 
SL3770 (parent strain, serum resistant) (Roantree et  al. 
1977). These strains were generously provided by professor 
Mikael Rhen, Karolinska Institutet. All strains were kept in 
glycerol stocks in −80 °C freezer, thawed and cultured for 
1–2 days on blood agar plates prior to experiments.
Serum bactericidal assay and whole blood bactericidal 
assay
The strains of Cani and Cyno were cultured on blood 
agar plates and incubated in 37 °C, at 5 % CO2 for 1 day. 
The strains did not grow in liquid broth and thus bacte-
rial colonies were harvested directly from agar plates 
and suspended in 3 ml phosphate-buffered saline (PBS), 
pH 7.4 to optical density 0.2–0.4 (determined by A600), 
which corresponded to approximately 1 × 107 to 1 × 108 
CFU/ml. The stock solution was further diluted for the 
various experiments.
The bactericidal assay was performed in two ways: (1) 
end-over-end assay using 1 ml total volume in Eppendorf 
tubes or (2) in the 96 microtiter well format using 100 µl 
total volume. The large volume was used for pooled sera 
and the small format was used for patient material with 
limited amounts. Serum was diluted in PBS prior to 
experiments.
For whole blood bactericidal assay, freshly drawn hep-
arinized blood from healthy volunteers was used. For the 
assay, 900  µl of blood and 100  µl (1–5  ×  106 CFU/ml) 
bacteria-PBS suspensions were mixed in Eppendorf tubes 
and incubated at 37  °C in an end-over-end tube rotator, 
6 rpm for 90 min. A viable count for each tube was per-
formed by serial dilutions and plating of 10 µl in dupli-
cates. Cani and Cyno were plated on blood agar plates 
and incubated in 37 °C, at 5 % CO2 for at least 2 days.
Results
Human serum kills Cani and Cyno in a time 
and concentration‑dependent way
To test the hypothesis that Cani would survive better in 
human serum than Cyno, the ATCC reference strains 
and clinical isolates of Cani and Cyno were studied in a 
classical serum killing assay. Notably, all Cani- and Cyno-
strains were rapidly killed by normal human serum from a 
healthy volunteer (90 % serum concentration, Fig. 1a, b). 
Already after 15  min, a distinct reduction was observed 
for both Cani and Cyno (1–3 log reduction for the Cani 
isolates and 4–6 log reduction for the Cyno isolates). 
Notably, after 60 min, no visible growth could be detected, 
except for the Cani reference strain, where a 3 log reduc-
tion was recorded (lowest level of detection 1000 CFU/ml, 
Fig.  1a, b). Surviving colonies were retested in the same 
serum killing assay and a complete reduction of bacte-
rial growth was observed, thus ruling out the selection of 
serum resistant mutants (data not shown).
Next, we tested different concentrations of human 
serum (5–90  %). A small reduction of bacterial counts 
occurred at 5 and 10 % serum concentrations, whereas a 
significant killing effect was observed at 20, 50 and 90 % 
serum concentrations (Fig. 1c). As controls for the system 
the Salmonella strain SL3769, known to be ‘serum sensi-
tive’ and Salmonella strain SL3770, known to be ‘serum 
resistant’ were used (Roantree et  al. 1977). Importantly, 
strain SL3770 was not killed by serum at any concentra-
tion tested, whereas strain SL3769 was rapidly killed by 
human serum. Notably, Cani and Cyno appeared to fol-
low the killing pattern of SL3769, thus supporting the 
notion that Cani and Cyno are susceptible to the bacteri-
cidal activity of human serum (Fig. 1c).
Clinical isolates of Cani and Cyno are killed by human 
whole blood and serum
To rule out the possibility that the ATCC reference 
strains were different than clinical strains, we also inves-
tigated our collection of clinical isolates of Cani and 
Cyno (described in Zangenah et  al. 2012). Most strains 
were readily killed by human whole blood and serum in 
a similar way as described for the ATCC-strains (~3 log 
reduction). Notably, there was some minor variation and 
a few strains produced viable colonies after 90  min of 
incubation together with human serum or whole blood 
(2.94–2.99 log reduction). Thus, there was some variabil-
ity in the fraction of surviving bacteria in different clini-
cal isolates. However, since the reduction of most strains 
was close to 3 log reduction (from an inocula of 106 CFU/
ml), we conclude that both the reference-strains (n = 2) 
and a collection of clinical isolates (n = 23) are suscepti-
ble to human serum.
Human sera from 12 healthy volunteers are active 
against Cani and Cyno
To rule out inter-volunteer variation we recruited 12 
healthy individuals (6 males and 6 females) who donated 
serum for our experiments. Importantly, sera from all 
individuals resulted in 2.91–3.00 log reduction of bacte-
rial counts of Cani and Cyno, respectively.
The magnitude of serum killing is reduced by large inocula
Next, we tested the role of various inocula in the serum 
killing assay. To mimic previous reports where Cani has 
been found to be serum resistant, we used 10  % serum 
concentration and 180 min of incubation (Shin et al. 2009). 
The magnitude of the serum killing effect was significantly 
reduced when large inocula (108–109 CFU/ml, circles) 
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were used, whereas a 1–2 log reduction was observed for 
lower inocula (Fig. 2a–c, squares and triangles).
Serum killing of Cani and Cyno is mediated via the classical 
pathway of the complement system
To study whether complement was involved in the kill-
ing of Cani and Cyno, human serum was heat inactivated 
in 56  °C for 30  min. Notably, this treatment completely 
abrogated the killing effect against both Cani and Cyno, 
suggesting complement dependent killing mechanisms 
(data not shown). To further dissect the killing mecha-
nism of human serum we used EGTA, which is often 
used to block the classical pathway of the complement 
system (Kochi and Johnson 1988). Indeed, this treatment 
completely inactivated the classical (0  %) and the lectin 
pathways (0  %), whereas the alternative pathway was 
Fig. 1 a, b Time-dependent bactericidal effect of serum against Cani and Cyno (90 % normal human serum was used). c Concentration-dependent 
bactericidal effect of normal human serum (NHS) against Cani, Cyno, the serum-sensitive Salmonella strain SL3769 and the serum-resistant Salmo-
nella strain SL3770. Experiments were performed three times in duplicate; incubation time 3 h, the lowest level of detection was 1000 CFU/ml. Error 
bars designate standard error of the mean (SEM)
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unaffected. Consequently, we added EGTA to the sera, 
which resulted in a significantly impaired killing effect 
against Cani (~60 % surviving bacteria) and Cyno (~25 % 
surviving bacteria). Notably, EGTA-treatment affected 
the killing of Cani to a larger extent than for Cyno, sug-
gesting that Cani and Cyno are killed via different com-
plement mediated pathways (Fig. 3).
To further study the role of the classical pathway, we 
obtained C1q-depleted serum. This serum was not effec-
tive against Cani and exhibited an impaired killing capac-
ity against Cyno (Fig.  3). In fact, increased growth was 
observed for Cani (~125  % surviving bacteria), whereas 
a significant killing activity against Cyno still was evi-
dent (~40 % surviving bacteria). This was in contrast to 
EGTA-treatment, which resulted in a significant reduc-
tion of bacterial growth for both Cani and Cyno (Fig. 3).
To specifically investigate the involvement of the lec-
tin pathway, we used sera from patients with mannose 
binding lectin (MBL) deficiency (0–3 %, reference 100 %). 
All patients exhibited potent killing activity against Cani 
and Cyno (Fig.  4). Notably, one patient had a slightly 
impaired killing capacity, but in addition to MBL-defi-
ciency this patient had a decreased function in the classi-
cal pathway (3 %) as determined by the clinical laboratory 
(Fig.  4, arrow). Combined with results from EGTA/
C1q-experiments, these data suggest that the classical 
pathway contributes significantly to the killing of Cani 
and that Cyno is killed via partly different mechanisms, 
possibly via the alternative complement pathway.
Sera from patients with a previous history of Cani‑sepsis 
have intact serum bactericidal activity and normal levels 
of immunoglobulins but have signs of MBL‑deficiency
Finally, whole blood and sera from patients with a recent 
history of sepsis with Cani was tested against the autolo-
gous Cani-strain (the strain originally isolated from the 
patient’s blood) and against another clinical Cani-isolate. 
Notably, all 3 patients exhibited full bactericidal activity 
for whole blood and serum against both the autologous 
strain and against the other clinical Cani-isolate. In fact, 
no viable bacteria were present after 90 min incubation in 
20 % serum (~5 log reduction for all strains, lowest level 
of detection 103 CFU/ml, data not shown). A detailed 
clinical and immunological workup was performed for 
these patients (Table 1). There was no obvious immuno-
deficiency present that could explain why these particular 
individuals experienced a severe Cani-infection. How-
ever, they were above 50  years of age, which have been 
described as a risk factor in previous reports (Lion et al. 
1996). One patient had a possible overconsumption of 
Fig. 2 Effect of inoculum size on serum killing activity against Cani (a), Cyno (b) and a serum sensitive Salmonella strain (SL3769). The serum con-
centration was 10 % and the time of incubation was 180 min. Experiments were performed three times in duplicate, lowest level of detection was 
1000 CFU/ml. Error bars designate standard error of the mean (SEM). Student’s t test was used to test for statistical significance. NHS normal human 
serum. Circles, squares and triangles designate large, medium and low inocula, respectively
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alcohol, and another patient was on iron supplementa-
tion; both circumstances are considered as risk factors 
for Cani-infections (Lion et al. 1996). In addition, 2 out of 
3 patients were deficient in the MBL-pathway, which was 
interesting but did not explain their infectious suscepti-
bility against Cani (Table 1).
Discussion
Statement of principal findings
Here we show that Cani and Cyno are readily killed by 
human serum in a time and concentration dependent 
way. This effect was dependent on complement activ-
ity since heat inactivation, EGTA and C1q-depletion 
impaired killing. Interestingly, Cani was more dependent 
on the classical pathway compared with Cyno, suggesting 
a possibly differential effect of the complement system 
against these bacteria. Further, experiments on patients 
with MBL-deficiency did not support a role for the lec-
tin pathway in the killing of Cani and Cyno. Finally, we 
investigated sera from three patients with a history of 
sepsis with Cani and found their sera to have normal 
complement activity as well as normal killing capacity 
against Cani.
Importantly, our observations are in contrast to studies 
in the literature where Cani has been shown to be com-
pletely resistant to human serum (Shin et al. 2009). The 
Fig. 3 Effect of EGTA-treatment and C1q-depleted serum on 
bactericidal activity against Cani (a) and Cyno (b). Experiments were 
performed 3 times in duplicate, the serum concentration was 20 %, 
lowest level of detection 1000 cfu and the time of incubation was 
90 min. Error bars designate the standard error of the mean (SEM). 
Student’s t test was used to test for statistical significance. NHS nor-
mal human serum
Fig. 4 Serum of MBL-deficient patients (P1–P4) compared with 
IgG-deficient patients (normal MBL activity, C1–C6) and normal 
human serum (NHS pooled from healthy controls). All sera exhibited 
significant killing activity against Cani and Cyno, except patient P1 
(arrow), which in addition to MBL-deficiency, had a reduced activity in 
the classical pathway. Inoculum was 1 × 106 CFU/ml, the lowest level 
of detection was 1000 CFU/ml, the serum concentration was 50 % 
and the time of incubation was 90 min
Table 1 Clinical history for  the patients with  a history 
of sepsis with C. canimorsus. MBL. mannose binding lectin
Patient 1 Patient 2 Patient 3
Age 60 66 72
Sex M M F
Animal Dog Dog Dog
Type of contact Minor wound Minor wound Minor wound
Wound-infection No No No
Sepsis Yes Yes Yes
Time to hospital 36 h Unknown 3 days
Clinical history Age. Alcohol Age. Iron supplementa-
tion
Age. Smoking
Sequelae No Balance-problems, 
fatigue
Fatigue
IgG 12.2 g/l 5.82 g/l 9.2 g/l
IgA 3.36 g/l 1.09 g/l 2.76 g/l
IgM 0.98 g/l 1.8 g/l 0.82 g/l
Classical 103 % 95 % 107 %
Alternative 95 % 66 % 115 %
MBL 0 % 1 % 100 %
Page 7 of 9Zangenah and Bergman  SpringerPlus  (2015) 4:517 
mechanism of serum resistance has been attributed to a 
putative glycosyltransferase, which affects the LPS-struc-
ture (Shin et al. 2009). Since our results are different from 
previous data we have tried to understand the reason for 
this discrepancy in detail.
There are several reasons why our results differ 
from previous reports
First, we have studied a collection of clinical isolates 
collected directly from clinical specimens of blood and 
wounds, respectively. The collection contains 23 strains 
and is extensively characterized with regards to diag-
nostic aspects (biochemistry, 16S rRNA sequencing and 
MALDI-TOF) (Zangenah et  al. 2012). In addition, we 
have performed whole genome sequencing of all iso-
lates, which have confirmed their identity and phylogeny 
(Zangenah et  al., unpublished). Second, we have elabo-
rated the serum bactericidal assay procedure in detail, 
including dependence of time, serum concentration and 
inoculum size. In fact, we show that there is a possible 
saturation effect with very large inocula (108–109 CFU/
ml). This is an unusual finding since it has been shown 
for E. coli that a high inoculum (1010 CFU) was equally 
well killed as a 6 log lower inoculum (104 CFU) (Olling 
1977). It is possible that this saturation effect could con-
tribute to the observation of serum resistance in previous 
papers, where high inocula (107 and 108 CFU/ml) have 
been used (Shin et al. 2007, 2009). Another aspect is the 
role of serum concentration in serum bactericidal assays. 
It has been suggested that too low serum concentration 
depletes the complement system of key components that 
may be diluted, i.e. the stoichiometry of key comple-
ment factors can be disturbed if too low concentrations 
are used, with a potential risk of having false negative 
results (Schreiber et  al. 1979). In fact, the alternative 
pathway was disturbed when human serum was diluted 
1:16 (Schreiber et al. 1979) and the activity of guinea pig 
serum was abrogated when used in concentrations lower 
than 10  % (Clas and Loos 1980). We have used 20  % 
serum for most of the experiments, and 10  % for some 
parts of the study. Previous reports have mainly used 
10  % serum, which possibly could have played a role in 
previous observations of ‘the serum resistant’ phenotype. 
In fact, our results indicate that 10 % may be too diluted 
serum to exert significant killing against Cani and Cyno 
(Fig. 1c). However, at the more physiological concentra-
tion of 20 % serum there is a significant reduction of both 
Cani and Cyno, which suggest that both these species are 
indeed to be described as ‘serum sensitive’. At least, it is 
fair to state that Cani and Cyno are significantly more 
sensitive to serum than truly “serum resistant strains”, 
such as Salmonella SL3770 (Fig.  1c) and Streptococ-
cus pyogenes (data not shown). Finally, we have studied 
n = 12 different individuals to evaluate a possible role of 
inter-individual variation and all sera tested resulted in 
2.94–3 log reduction of all tested strains. Even though 
not complete killing was observed for all strains or sera 
tested, our data do not support the notion that Cani and 
Cyno should be described as ‘serum resistant’ bacteria.
Nevertheless, several concerns against our results  
may be raised
First, could our assay conditions have rendered the bac-
teria falsely serum sensitive? We do acknowledge that the 
assay conditions are crucial for correct results. Also in our 
hands the results varied depending on which method that 
was used. Importantly, the methods used here (end-over-
end rotation or 96 well microtiter plate) gave robust and 
reproducible results, again corroborating the important 
role of serum in the killing of these bacteria. Second, we 
have used the well described Salmonella strain SL3770, 
which is known to be serum resistant. This strain was 
completely resistant to serum mediated killing up to 90 % 
serum concentration (Fig.  1c). Importantly, both Cani 
and Cyno followed approximately the same killing kinet-
ics as the serum susceptible Salmonella strain SL3769, 
which further indicates that Cani and Cyno should be 
considered as ‘serum-sensitive’. The Salmonella strain 
SL3769 has a mutation in a glycosyl transferase encoded 
by the gene rfaG, which lead to increased susceptibility 
to a number of antibiotics and to killing by human serum 
(Roantree et al. 1977). Finally, an additional problem could 
be that bacteria were scraped off the plates and not grown 
to mid logarithmic phase prior to experiments. This is a 
valid point of criticism since mid-logarithmic phase bac-
teria are considered to be a gold standard in antimicrobial 
assays. Bacteria that are scraped off from plates constitute 
a mixture between growing, dead and dormant bacte-
ria (stationary phase) and are thus not perfect for use in 
antimicrobial assays. However, Cani and Cyno are very 
difficult to grow in broth and we could not obtain mid 
log phase broths for our experiments. Therefore, we used 
the second best approach, i.e. scraping bacteria off plates, 
which probably have the net effect that bacteria appear 
to be less resistant against various antimicrobial agents, 
including complement deposition. Dividing bacteria in 
mid log phase are considered to be more susceptible to 
killing by both antibiotics (Lewis 2007) and antimicro-
bial peptides (Kristian et al. 2007). This is important since 
it has been shown for E. coli that susceptible strains can 
appear to be completely refractory to serum bactericidal 
effects if bacteria are harvested before the onset of the 
exponential phase (Davis and Wedgwood 1965). Thus, it 
is possible that such circumstances could be part of the 
explanation for why previous reports have concluded that 
Cani has a serum resistant phenotype.
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What do these results mean?
We can conclude that Cani and Cyno indeed are sensi-
tive to human serum. This is potentially important since 
it is well described that individuals with various degrees 
of immunodeficiency are more susceptible to infections 
with Cani (Lion et  al. 1996). For example, patients with 
splenectomy, alcoholism, complement deficiency or 
various cancers have been described with severe forms 
of Cani-infections. However, the precise mechanisms 
behind this increased susceptibility have not been clari-
fied. In addition, approximately half of patients with 
invasive Cani-infection have no defined immunosup-
pressive disorder. Here we had the possibility to perform 
clinical and laboratory investigations of three patients 
with a history of Cani sepsis. The clinical picture was 
similar: a contact with the house hold dog resulted in 
an innocuous wound, for which they did not seek medi-
cal assistance initially. However, after 2–3 days a sudden 
onset of fever, chills and malaise occurred. This resulted 
in medical emergency visits, sometimes requiring an 
ambulance. In the emergency room, ‘sepsis of unknown 
cause’ was diagnosed and empirical treatment with intra-
venous cephalosporins resulted in a rapid recovery. After 
5–7 days, an answer came from the clinical bacteriology 
department with a positive blood culture of Cani. All had 
normal activity of the classical and alternative comple-
ment pathways, but 2/3 patients had a deficiency in the 
MBL-pathway. Notably, all 3 patients’ sera killed their 
autologous strain of Cani. Thus, the explanation for their 
susceptibility to this bacterium has not been clarified but 
an involvement of opsonization and uptake of phagocytic 
cells cannot be ruled out.
Unanswered questions and future research
Combined, our results imply that whole blood and serum 
rapidly kills these bacteria. Since our approach includes 
many clinical strains, a large number of healthy volun-
teers, patients with MBL-deficiency as well as patients 
with a history of Cani-sepsis, we are confident to con-
clude that both Cani and Cyno are indeed sensitive to 
human whole blood and serum.
The current results could be important for the increas-
ing group of immunocompromised patients in hospi-
tals and society. Notably, in Sweden there are 1 million 
dogs and many patients spend time with their house hold 
dogs after cancer treatment or transplantation. It is well 
known that the complement system may be impaired 
after transplantation, which could have a profound 
impact on these types of infections. Thus, a detailed 
understanding of immunity against Cani and Cyno could 
direct therapeutic or prophylactic strategies in the immu-
nocompromised host, including transplanted or cancer 
patients.
Authors’ contributions
SZ and PB planned and designed the study. SZ carried out the experimen-
tal work. SZ and PB write the manuscript together. Both authors read and 
approved the final manuscript.
Author details
1 Div of Clinical Microbiology, F68, Department of Laboratory Medicine, 
Karolinska Institutet and Karolinska University Hospital, Huddinge, Stockholm, 
Sweden. 2 Department of Medicine, Center for Infectious Medicine (CIM), 
Karolinska Institutet and Karolinska University Hospital, Huddinge, Stockholm, 
Sweden. 
Acknowledgements
Linda Björkhem-Bergman, MD, PhD, is gratefully acknowledged for critical 
reading of the manuscript. PB was supported by grants from the Swedish 
Research Council (VR), the Stockholm County Council (ALF) and Karolinska 
Institutet.
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interest.
Received: 20 June 2015   Accepted: 3 September 2015
References
Abdullah M, Nepluev I, Afonina G, Ram S, Rice P, Cade W, Elkins C (2005) Killing 
of dsrA mutants of Haemophilus ducreyi by normal human serum occurs 
via the classical complement pathway and is initiated by immunoglobu-
lin M binding. Infect Immun 73(6):3431–3439
Bergman P, Norlin AC, Hansen S, Rekha RS, Agerberth B, Björkhem-Bergman 
L, Ekström L, Lindh JD, Andersson J (2012) Vitamin D3 supplementation 
in patients with frequent respiratory tract infections: a randomised and 
double-blind intervention study. BMJ Open 2(6):e001663
Bobo RA, Newton EJ (1976) A previously undescribed gram-negative bacillus 
causing septicemia and meningitis. Am J Clin Pathol 65(4):564–569
Brenner DJ, Hollis DG, Fanning GR, Weaver RE (1989) Capnocytophaga canimor-
sus sp. nov. (formerly CDC group DF-2), a cause of septicemia following 
dog bite, and C. cynodegmi sp. nov., a cause of localized wound infection 
following dog bite. J Clin Microbiol 27(2):231–235
Butler T (2015)  Capnocytophaga canimorsus: an emerging cause of sepsis, 
meningitis, and post-splenectomy infection after dog bites. Eur J Clin 
Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 34(7):1271–1280
Butler T, Johnston KH, Gutierrez Y, Aikawa M, Cardaman R (1985) Enhance-
ment of experimental bacteremia and endocarditis caused by dysgonic 
fermenter (DF-2) bacterium after treatment with methylprednisolone 
and after splenectomy. Infect Immun 47(1):294–300
Clas F, Loos M (1980) Killing of the S and Re forms of Salmonella minnesota 
via the classical pathway of complement activation in guinea-pig and 
human sera. Immunology 40(4):547–556
Davis SD, Wedgwood RJ (1965) Kinetics of the Bactericidal Action of Normal 
Serum on Gram-Negative Bacteria. J Immunol 95:75–79
Gasch O, Fernandez N, Armisen A, Verdaguer R, Fernandez P (2009) Commu-
nity-acquired  Capnocytophaga canimorsus meningitis in adults: report 
of one case with a subacute course and deafness, and literature review. 
Enferm Infecc Microbiol Clin 27(1):33–36
Hicklin H, Verghese A, Alvarez S (1987) Dysgonic fermenter 2 septicemia. Rev 
Infect Dis 9(5):884–890
Khawari AA, Myers JW, Ferguson DA Jr, Moorman JP (2005) Sepsis and menin-
gitis due to Capnocytophaga cynodegmi after splenectomy. Clin Infect 
Dis Off Publ Infect Dis Soc Am 40(11):1709–1710
Kochi SK, Johnson RC (1988) Role of immunoglobulin G in killing of Borrelia burg-
dorferi by the classical complement pathway. Infect Immun 56(2):314–321
Kristian SA, Timmer AM, Liu GY, Lauth X, Sal-Man N, Rosenfeld Y, Shai Y, Gallo 
RL, Nizet V (2007) Impairment of innate immune killing mechanisms 
by bacteriostatic antibiotics. FASEB J Off Publ Fed Am Soc Exp Biol 
21(4):1107–1116
Page 9 of 9Zangenah and Bergman  SpringerPlus  (2015) 4:517 
Lewis K (2007) Persister cells, dormancy and infectious disease. Nat Rev Micro-
biol 5(1):48–56
Lion C, Escande F, Burdin JC (1996)  Capnocytophaga canimorsus infections 
in human: review of the literature and cases report. Eur J Epidemiol 
12(5):521–533
Oehler RL, Velez AP, Mizrachi M, Lamarche J, Gompf S (2009) Bite-related 
and septic syndromes caused by cats and dogs. Lancet Infect Dis 
9(7):439–447
Olling S (1977) Sensitivity of gram-negative bacilli to the serum bactericidal 
activity: a marker of the host-parasite relationship in acute and persisting 
infections. Scand J Infect Dis Suppl 10:1–40
Renzi F, Manfredi P, Mally M, Moes S, Jeno P, Cornelis GR (2011) The N-glycan 
glycoprotein deglycosylation complex (Gpd) from  Capnocytophaga 
canimorsus deglycosylates human IgG. PLoS Pathog 7(6):e1002118
Roantree RJ, Kuo TT, MacPhee DG (1977) The effect of defined lipopolysaccha-
ride core defects upon antibiotic resistances of Salmonella typhimurium. 
J Gen Microbiol 103(2):223–234
Sarma PS, Mohanty S (2001) Capnocytophaga cynodegmi cellulitis, bactere-
mia, and pneumonitis in a diabetic man. J Clin Microbiol 39(5):2028–2029
Schreiber RD, Morrison DC, Podack ER, Muller-Eberhard HJ (1979) Bactericidal 
activity of the alternative complement pathway generated from 11 
isolated plasma proteins. J Exp Med 149(4):870–882
Shahani L, Khardori N (2014) Overwhelming Capnocytophaga canimorsus 
infection in a patient with asplenia. BMJ Case Rep 2014:bcr2013202768. 
doi:10.1136/bcr-2013-202768
Shin H, Mally M, Kuhn M, Paroz C, Cornelis GR (2007) Escape from immune 
surveillance by  Capnocytophaga canimorsus. J Infect Dis 195(3):375–386
Shin H, Mally M, Meyer S, Fiechter C, Paroz C, Zaehringer U, Cornelis GR (2009) 
Resistance of  Capnocytophaga canimorsus to killing by human comple-
ment and polymorphonuclear leukocytes. Infect Immun 77(6):2262–2271
Suzuki M, Kimura M, Imaoka K, Yamada A (2010) Prevalence of  Capnocy-
tophaga canimorsus and Capnocytophaga cynodegmi in dogs and cats 
determined by using a newly established species-specific PCR. Vet 
Microbiol 144(1–2):172–176
Ugai T, Sugihara H, Nishida Y, Yamakura M, Takeuchi M, Matsue K (2014) 
Capnocytophaga canimorsus sepsis following BMT in a patient with 
AML: possible association with functional asplenia. Bone Marrow Transpl 
49(1):153–154
Zangenah S, Ozenci V, Borang S, Bergman P (2012) Identification of blood 
and wound isolates of C. canimorsus and C. cynodegmi using VITEK2 and 
MALDI-TOF. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 
31(10):2631–2637
